Unheard of to have a trial with 19 participants show statistical signifigance easily beating .05 standard.....
Big pharma runs trials with 5000 patients to show an overall benefit of life extension for a month that has huge side effects. And they call that a great new drug...Pfff to the drugs that dont cure,have horendous side effects and effectivness decreases quickly.
Ann: FDA Grants Orphan Drug Designation for Revascor, page-273
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
-0.020(1.75%) |
Mkt cap ! $1.307B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.11 | $4.735M | 4.148M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 48743 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 42811 | 12 |
View Market Depth
| Last trade - 12.28pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |